Topic: American Society Of Clinical Oncology
In patients with advanced non-small cell lung cancer (NSCLC), new drugs and drug combinations can prolong survival, while hormone therapy among menopausal females with lung cancer is associated with increased mortality risk, according to research presented at the annual meeting of the ...
70 abstracts accepted for inclusion in the ASCO annual meeting Merck KGaA, a leader in personalizing cancer care, continues to drive the global effort to ensure patients receive therapies tailored to their cancer. Merck has an ongoing commitment to the advancement of ...
Of more than 4,000 cancer studies presented at the recent annual meeting of the American Society of Clinical Oncology, those exploring the effects of targeted therapy cetuximab (Erbitux, ImClone) combined with platinum-based chemotherapy generated the most buzz. "The results of our randomized ...
Jun 2, 2008 - Pfizer announced today results from several clinical trials further describing the activity of its investigational compound CP-751,871 in non-small cell lung cancer (NSCLC) and Ewing's Sarcoma, both diseases with high unmet medical need. "These results help us to ...
Jun 2, 2008 - Pfizer Inc announced today as part of its commitment to oncology that it expects to start a total of seven Phase 3 studies in 2008; two are open and enrolling, and five are planned to begin by the ...
Landmark Study Shows Increased Survival for Non-Small Cell Lung Cancer Today, Lung Cancer Alliance (LCA) hailed the release of promising data from the pivotal Phase III First Line in Lung Cancer with Erbitux(R) (FLEX) Study. The data, presented at the American Society ...
The American Society of Clinical Oncology annual meeting, which started Friday in Chicago, couldn't get any bigger for ImClone Systems (IMCL) and its Erbitux partners Bristol-Myers Squibb (BMY) and the German Merck (no relation to the U.S.-based Merck).. ) It's expected to ...
With this year's annual American Society of Clinical Oncology [ASCO] meeting coming up this weekend I thought I might give a heads up on a few companies whose presentations might look interesting to investors. By far the most important data to be ...
From Around the Web
Video Gallery
-
American Society of Clinical Oncology (ASCO ...
A partnership between US Figure Skating and the American Society ...2011-05-10 -
NCI Director's Address, Annual Meeting ...
Harold Varmus delivered the NCI Director's Address at the ...2011-06-27 -
Pharma Strategy Blog ASCO 2011 Preview
Preview of American Society of Clinical Oncology (ASCO) 2011 annual ...2011-05-30
